PSEN1 and Alzheimer disease: Various GEFB approaches have shown great utility in drug discovery [232], including the use of an automated high-throughput calcium imaging assay with FRET-based calcium indicator, Yellow Cameleon 3.6, to screen compounds capable of treating endoplasmic reticulum calcium homeostasis disruption linked to familial AD, mutant PSEN1 [234].